BIOMAT Database Logo BIOMAT Database Logo

Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation. 2014

Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
School of Medicine, Xi'an Jiaotong University, No. 76, Yanta West Road, Xi'an, Shaanxi Province 710061, PR China.

A series of novel biphenyl urea derivates were synthesized and investigated for their potential to inhibit vascular endothelial growth factor receptor-2 (VEGFR-2). In particular, A7, B3 and B4 displayed significant enzymatic inhibitory activities, with IC₅₀ values of 4.06, 4.55 and 5.26 nM. Compound A7 exhibited potent antiproliferative activity on several cell lines. SAR study suggested that the introduction of methyl at ortho-position of the biphenyl urea and tertiary amine moiety could improve VEGFR-2 inhibitory activity and antitumor effects. Molecular docking indicated that the urea moiety formed four hydrogen bonds with DFG residue. These biphenyl ureas could serve as promising lead compounds for further optimization.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D040301 Vascular Endothelial Growth Factor Receptor-2 A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF. VEGFR-2,Fetal Liver Kinase-1,Flk-1 Protein,Flk-1 Receptor Tyrosine Kinase,KDR Tyrosine Kinase,Kinase Insert Domain Receptor,VEGF Receptor Flk-1,VEGF Receptor KDR,Fetal Liver Kinase 1,Flk 1 Protein,Flk 1 Receptor Tyrosine Kinase,Flk-1, VEGF Receptor,KDR, VEGF Receptor,Tyrosine Kinase, KDR,VEGF Receptor Flk 1,Vascular Endothelial Growth Factor Receptor 2

Related Publications

Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, Synthesis and Biological Evaluation of Uracil Derivatives as Novel VEGFR-2 Inhibitors.
January 2018, Current pharmaceutical design,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors.
November 2010, Bioorganic & medicinal chemistry letters,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors.
August 2018, Bioorganic chemistry,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors.
November 2019, European journal of medicinal chemistry,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors.
January 2018, Archiv der Pharmazie,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Novel 2-oxo-2-phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR-2 inhibitors: Design, synthesis, and anticancer evaluation.
February 2023, Archiv der Pharmazie,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
March 2020, Molecules (Basel, Switzerland),
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors.
January 2022, Frontiers in chemistry,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling.
June 2019, Anti-cancer drugs,
Chen Wang, and Hongping Gao, and Jinyun Dong, and Yanmin Zhang, and Ping Su, and Yaling Shi, and Jie Zhang
New 2,4-disubstituted-2-thiopyrimidines as VEGFR-2 inhibitors: Design, synthesis, and biological evaluation.
November 2019, Archiv der Pharmazie,
Copied contents to your clipboard!